Skip to main content
. 2019 Feb 26;7(4):419–430. doi: 10.12998/wjcc.v7.i4.419

Table 4.

Programmed death-ligand 1 expression results of the programmed death-ligand 1 immunoreactive cases (n = 20)

Case No. Used formalin PD-L1 expression; P = 0.4605 (6 h-48 h vs 1 wk) 1
Assessment (Cut-off 1%) Assessment (Cut-off 10%) Assessment (Cut-off 50%)
6 h 24 h 48 h 1 wk
2 10% F 10 10 10 1-9 + + -
4 10% F 80 80 90 90 + + +
5 10% F 0 0 0 1-9 + - -
8 10% F 0 0 1-9 1-9 + - -
9 10% F 0 1-9 0 1-9 + - -
10 10% F 40 30 30 40 + + -
11 10% F 1-9 0 10 10 + + -
12 10% F 1-9 1-9 1-9 0 + - -
14 10% F 100 1-9 30 60 + + +
16 10% F 1-9 10 1-9 1-9 + + -
18 10% F 20 60 40 40 + + +
19 10% F 1-9 1-9 1-9 0 + - -
20 10% F 80 80 20 1-9 + + +
21 10% F 1-9 0 1-9 1-9 + - -
25 10% NBF 10 0 10 0 + + -
27 10% NBF 20 70 30 1-9 + + +
29 10% NBF 1-9 1-9 0 1-9 + - -
30 10% NBF 100 100 100 100 + + +
31 10% NBF 0 1-9 10 1-9 + + -
32 10% NBF 70 80 90 90 + + +
1

Simultaneous tests for linear hypotheses based on a linear mixed effects model.

F: Formalin; NBF: Neutral buffered formalin.